International Stem Cell Corporation Completes Clinical Testing of a New Compound – CNNMoney
|
International Stem Cell Corporation Completes Clinical Testing of a New Compound
CNNMoney International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today that the Company completed clinical testing of a recently discovered … |
